Medicine: papers

Filters2 filters applied

Topic

Status

Corrected
No notice
Not checked
From publisher notices and Retraction Watch. Not checked means nobody has looked yet.

Year

Readable here

Study type

Licence

CC BY

68 papers1 Corrected 8 with full text Questions on this topic

1 filter appliedYear: 2010 to 2019 Clear all

Research of domestic market medicinal agents based on Minoxidil and it’s derivatives that are used in treatments for Alopecia
Zhamali Karim, N. О. Tkachenko, V. V. Hladyshev et al. · Aktualʹnì Pitannâ Farmacevtičnoï ì Medičnoï Nauki ta Praktiki · 2019
Abstract onlyNot checked
An analysis on rational use and affordability of medicine after the implementation of National Essential Medicines Policy and Zero Mark-up Policy in Hangzhou, China.
Wenhui Mao, Yunyu Huang, Wen Chen · PLoS ONE · 2019
Abstract onlyNot checked
Relationship between pharmaceutical pricing strategies with price, availability, and affordability of cardiovascular disease medicines: surveys in Qatar and Lebanon
N. Abdel Rida, M. I. Mohamed Ibrahim, Z. U. D. Babar · BMC Health Services Research · 2019
Abstract onlyNot checked
What Can We Learn About the Processes of Regulation of Tuberculosis Medicines From the Experiences of Health Policy and System Actors in India, Tanzania, and Zambia?
Kabir Sheikh, Mukund Uplekar · International Journal of Health Policy and Management · 2016
Abstract onlyNot checked
Essential medicine list 2011
Keshab Mukhopadhyay, Ritesh Singh · Muller Journal of Medical Sciences and Research · 2014
Abstract onlyNot checked
Patent and exclusivity status of essential medicines for non-communicable disease.
Tim K Mackey, Bryan A Liang · PLoS ONE · 2012
Abstract onlyNot checked
Will you support a patient-centred R&D agreement?—Response from Philippe Douste-Blazy
Philippe Douste-Blazy · The Lancet Global Health · 2017
Abstract onlyNot checked
Knowledge and Perceptions of Final-Year Medical Students in Yemeni Universities about Generic Medicines
Gamil Q. Othman, Mahfoudh A. M. Abdulghani, Hyam A. AlHyfi et al. · Yemeni Journal for Medical Sciences · 2016
Abstract onlyNot checked
Pharmacoeconomics and its implication on priority-setting for essential medicines in Tanzania: a systematic review
Mori Amani, Robberstad Bjarne · BMC Medical Informatics and Decision Making · 2012
Abstract onlyNot checked
Payers’ views of the changes arising through the possible adoption of Adaptive Pathways
Michael Ermisch, Anna Bucsics, Patricia Vella Bonanno et al. · Frontiers in Pharmacology · 2016
Abstract onlyNot checked
“Market withdrawals” of medicines in Germany after AMNOG: a comparison of HTA ratings and clinical guideline recommendations
Thomas R. Staab, Miriam Walter, Sonja Mariotti Nesurini et al. · Health Economics Review · 2018
Abstract onlyNot checked
Comparative Analysis of Legislative Requirements About Patients' Access to Biotechnological Drugs for Rare Diseases in Central and Eastern European Countries
Maria Kamusheva, Manoela Manova, Manoela Manova et al. · Frontiers in Pharmacology · 2018
Abstract onlyNot checked
Problems of Economic Security of Health Care Institutions
Anna Vitiuk, Alina Bondarchuk · Соціальна економіка · 2019
Abstract onlyNot checked
Moderating the impact of patent linkage on access to medicines: lessons from variations in South Korea, Australia, Canada, and the United States
Kyung-Bok Son, Ruth Lopert, Deborah Gleeson et al. · Globalization and Health · 2018
Abstract onlyNot checked
Value-based medicine: concepts and application
Jong-Myon Bae · Epidemiology and Health · 2015
Abstract onlyNot checked
Medicine of the Future: Opportunities for Breakthrough through the Prism of Technology Foresight
Ilya Kaminskiy, Ludmila Ogorodova, Maxim Patrushev et al. · Foresight and STI Governance · 2013
Abstract onlyNot checked
Health-sector reform in China and access to essential medicines
Hans V Hogerzeil, Sun Jing · The Lancet Global Health · 2013
Abstract onlyNot checked
Decision-making criteria for medicine reimbursement in Slovenia: an expert panel discussion
Andreja Detiček, Andrej Janzic, Igor Locatelli et al. · BMC Health Services Research · 2018
Abstract onlyNot checked
Timely Access to Priority Medicines in Europe
Enrico Bosone, Giovanni Giuliani, Nicoletta Martone et al. · Medicine Access @ Point of Care · 2017
Abstract onlyNot checked
Clinical and economic issues complicating cost-effectiveness evaluation of orphan diseases
Nuijten Mark J.C., Pronk Marja H., Hutton John et al. · The EuroBiotech Journal · 2017
Abstract onlyNot checked